| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/12/2002 | CA2448112A1 Lces as modifiers of the p53 pathway and methods of use |
| 12/12/2002 | CA2448107A1 Marks as modifiers of the p53 pathway and methods of use |
| 12/12/2002 | CA2447732A1 Antineoplastic combinations |
| 12/12/2002 | CA2446160A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug |
| 12/12/2002 | CA2436408A1 Modified psma ligands and uses related thereto |
| 12/12/2002 | CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof |
| 12/11/2002 | WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 12/11/2002 | EP1264612A1 Method for nasal application of a medicinal substance |
| 12/11/2002 | EP1264601A2 Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
| 12/11/2002 | EP1264600A1 Immune enhancement compositions and use thereof |
| 12/11/2002 | EP1263982A1 Phosphatidyl serine receptors and uses thereof |
| 12/11/2002 | EP1263956A2 Human genes and gene expression products |
| 12/11/2002 | EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 12/11/2002 | EP1263953A2 Novel family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 12/11/2002 | EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2002 | EP1263943A1 Protein c derivatives |
| 12/11/2002 | EP1263803A1 Embolic compositions |
| 12/11/2002 | EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 12/11/2002 | EP1263787A2 G-protein coupled receptors |
| 12/11/2002 | EP1263786A2 Methods and compositions for immunoregulation |
| 12/11/2002 | EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer |
| 12/11/2002 | EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells |
| 12/11/2002 | EP1263768A2 Chimeric neuropeptide y receptors |
| 12/11/2002 | EP1263767A2 Beta netrin and uses thereof |
| 12/11/2002 | EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 12/11/2002 | EP1263746A1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments |
| 12/11/2002 | EP1263732A1 Corticotropin releasing factor antagonists |
| 12/11/2002 | EP1263718A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263714A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 12/11/2002 | EP1263471A2 Antimicrobial compounds and formulations |
| 12/11/2002 | EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 12/11/2002 | EP1263467A1 Improved paste formulations |
| 12/11/2002 | EP1263466A1 Methods and compositions for dietary supplements |
| 12/11/2002 | EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 12/11/2002 | EP1263458A1 Lowering serum lipids |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263455A2 Uses of bombesin receptor 3 |
| 12/11/2002 | EP1263454A2 Methods for enhancing the bioavailability of a drug |
| 12/11/2002 | EP1263447A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 12/11/2002 | EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 12/11/2002 | EP1263445A1 Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor |
| 12/11/2002 | EP1263443A1 Metalloproteinase inhibitors for the treatment of respiratoty diseases |
| 12/11/2002 | EP1263442A1 TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS |
| 12/11/2002 | EP1263440A2 Cephalotaxine alkaloid combination compositions and uses thereof |
| 12/11/2002 | EP1263437A2 Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| 12/11/2002 | EP1263436A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
| 12/11/2002 | EP1263435A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 12/11/2002 | EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP1263425A1 Use of comt inhibitors as analgesics |
| 12/11/2002 | EP1263423A2 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 |
| 12/11/2002 | EP1263422A1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 12/11/2002 | EP1263418A2 Cartilage enhancing food supplements and methods of preparing the same |
| 12/11/2002 | EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/11/2002 | EP1263300A1 Improvements in or relating to solubilisation of flavonols |
| 12/11/2002 | EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 12/11/2002 | EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid |
| 12/11/2002 | EP0942741B1 Lectin compositions and uses thereof |
| 12/11/2002 | EP0859630B1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 12/11/2002 | EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 12/11/2002 | EP0752813B1 Inhibitors of metazoan parasite proteases |
| 12/11/2002 | CN1385036A Communications system |
| 12/11/2002 | CN1384827A Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 12/11/2002 | CN1384756A Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure |
| 12/11/2002 | CN1384754A Method and composition for treating prostate cancer |
| 12/11/2002 | CN1384750A Plant extract mixtures and their uses |
| 12/11/2002 | CN1384748A Mesoprogestins (progesterone receptor modulators) as component of female contraceptives |
| 12/11/2002 | CN1384746A 单位剂量形式 Unit dosage forms |
| 12/11/2002 | CN1384734A Surface modified particulate compositions of biologically active substances |
| 12/11/2002 | CN1384733A Dry powder compositions having improved dispersivity |
| 12/11/2002 | CN1384104A Usage, kit and composition of pyrrole derivative |
| 12/11/2002 | CN1383823A Method of applying MEK inhibitor to treat or inhibit neutrophil chemotaxis |
| 12/11/2002 | CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum |
| 12/10/2002 | US6492507 Polynucleotides encoding human eosinophil-derived basic protein |
| 12/10/2002 | US6492504 Nucleotide sequence of mammastatin and methods of use |
| 12/10/2002 | US6492499 Human pancreatitis-associated protein |
| 12/10/2002 | US6492429 Apocynin and an inhibitor of inducible nitric oxide synthase |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer |
| 12/10/2002 | US6492371 Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of Parkinson's Disease |
| 12/10/2002 | US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 12/10/2002 | US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 12/10/2002 | US6492339 Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof |
| 12/10/2002 | US6492333 Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors |
| 12/10/2002 | US6492332 Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
| 12/10/2002 | US6492331 NL8 tie ligands homologues |
| 12/10/2002 | US6492326 Containing a pentapeptide |
| 12/10/2002 | US6492325 Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease |
| 12/10/2002 | US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that |
| 12/10/2002 | US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf |
| 12/10/2002 | US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 12/10/2002 | US6491954 Anti-snoring composition |
| 12/10/2002 | US6491944 Method for making spirillicide |
| 12/10/2002 | US6491933 Personal care articles comprising hotmelt compositions |
| 12/10/2002 | US6491893 Compounds for targeting and imaging infection and inflammation |